Short and Long-Term Outcomes of Diabetes Mellitus in Patients with Autoimmune Pancreatitis after Steroid Therapy
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Autoimmune pancreatitis (AIP) is frequently associated with diabetes mellitus (DM). This study evaluated the effect of steroid therapy on the course of DM in AIP. Methods: Glucose tolerance was examined in 69 patients with AIP. DM onset was classified as either a simultaneous onset with AIP or an exacerbation of pre-existing DM. Based on the changes in the HbA1c levels and insulin dose, the responses of DM to steroids were classified as improved, no change, or worsened. Results: Thirty (46%) patients were diagnosed as having DM (simultaneous onset, n=17; pre-existing, n=13). Three months after starting the steroid treatment, the DM improved in 13 (54%) of 24 DM patients. The DM improved in 55%, had no change in 36%, and worsened in 9% of the 11 simultaneous onset DM patients, and it improved in 54%, had no change in 31%, and worsened in 15% of the 13 pre-existing DM patients. At approximately 3 years after starting the steroid treatment, the DM improved in 10 (63%) of 16 patients. The pancreatic exocrine function improved in parallel with the changes in the DM in seven patients. Conclusions: Because approximately 60% of DM associated with AIP is responsive to steroids in the short- and long-terms, marked DM associated with AIP appears to be an indication for steroid therapy.
Abstract
Background/Aims: Autoimmune pancreatitis (AIP) is frequently associated with diabetes mellitus (DM). This study evaluated the effect of steroid therapy on the course of DM in AIP. Methods: Glucose tolerance was examined in 69 patients with AIP. DM onset was classified as either a simultaneous onset with AIP or an exacerbation of pre-existing DM. Based on the changes in the HbA1c levels and insulin dose, the responses of DM to steroids were classified as improved, no change, or worsened. Results: Thirty (46%) patients were diagnosed as having DM (simultaneous onset, n=17; pre-existing, n=13). Three months after starting the steroid treatment, the DM improved in 13 (54%) of 24 DM patients. The DM improved in 55%, had no change in 36%, and worsened in 9% of the 11 simultaneous onset DM patients, and it improved in 54%, had no change in 31%, and worsened in 15% of the 13 pre-existing DM patients. At approximately 3 years after starting the steroid treatment, the DM improved in 10 (63%) of 16 patients. The pancreatic exocrine function improved in parallel with the changes in the DM in seven patients. Conclusions: Because approximately 60% of DM associated with AIP is responsive to steroids in the short- and long-terms, marked DM associated with AIP appears to be an indication for steroid therapy.
참고문헌 (15)
- Okazaki K, "Japanese clinical guidelines for autoimmune pancreatitis", Pancreas, 38, pp.849~866 (2009)
- Kamisawa T, "Autoimmune pancreatitis and IgG4-related sclerosing disease", Nat Rev Gastroenterol Hepatol, 7, pp.401~409 (2010)
- Tanaka S, "Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis", Lancet, 356, pp.910~911 (2000)
- Kamisawa T, "Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy", Pancreas, 27, pp.235~238 (2003)
- Ito T, "Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis", Pancreas, 34, pp.254~259 (2007)
- Ito T, "Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan", J Gastroenterol, 42(Suppl 18), pp.50~58 (2007)
- Nishino T, "Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy", Intern Med, 45, pp.497~501 (2006)
- Nishimori I, "Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan", Pancreas, 32, pp.244~248 (2006)
- Frulloni L, "Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment", Pancreatology, 10, pp.129~133 (2010)
- Otsuki M, "Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis", J Gastroenterol, 43, pp.403~408 (2008)
- Seino Y, "Report of the Committee on the classification and diagnostic criteria of diabetes mellitus: the Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus", Diabetol Int, 1, pp.2~20 (2010)
- Kamisawa T, "Standard steroid treatment for autoimmune pancreatitis", Gut, 58, pp.1504~1507 (2009)
- Kamisawa T, "Japanese consensus guidelines for management of autoimmune pancreatitis: III. treatment and prognosis of AIP", J Gastroenterol, 45, pp.471~477 (2010)
- Kamisawa T, "Management strategies for autoimmune pancreatitis", Expert Opin Pharmacother, 12, pp.2149~2159 (2011)
- Tanaka S, "Evidence of primary beta-cell destruction by T-cells and beta-cell differentiation from pancreatic ductal cells in diabetes associated with active autoimmune chronic pancreatitis", Diabetes Care, 24, pp.1661~1667 (2001)